The store will not work correctly when cookies are disabled.
5-Oxy-1-propyl-1H-pyrido[2,3-b]quinoxalin-2-ylideneamine
ID: ALA165708
PubChem CID: 44377829
Max Phase: Preclinical
Molecular Formula: C14H14N4O
Molecular Weight: 254.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCn1c(=N)ccc2c1nc1ccccc1[n+]2[O-]
Standard InChI: InChI=1S/C14H14N4O/c1-2-9-17-13(15)8-7-12-14(17)16-10-5-3-4-6-11(10)18(12)19/h3-8,15H,2,9H2,1H3
Standard InChI Key: YIAQQGLZIFDAAY-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
4.5417 -3.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0667 -4.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0667 -4.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5917 -5.0167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5500 -5.0250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1167 -4.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5875 -3.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -4.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1042 -4.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -3.2167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6375 -5.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6000 -5.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -3.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -5.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -5.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9917 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9917 -4.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -6.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 1 2 0
4 2 1 0
5 9 1 0
6 1 1 0
7 10 1 0
8 3 1 0
9 6 1 0
10 8 2 0
11 1 1 0
12 7 2 0
13 4 1 0
14 6 2 0
15 9 2 0
16 13 1 0
17 14 1 0
18 17 2 0
19 16 1 0
2 5 2 0
15 18 1 0
7 4 1 0
M CHG 2 1 1 11 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 254.29 | Molecular Weight (Monoisotopic): 254.1168 | AlogP: 1.71 | #Rotatable Bonds: 2 |
Polar Surface Area: 68.61 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.68 | CX LogP: 1.62 | CX LogD: 1.61 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.43 | Np Likeness Score: -0.72 |
References
1. Glazer EA, Chappel LR.. (1982) Pyridoquinoxaline N-oxides. 1. A new class of antitrichomonal agents., 25 (7): [PMID:7108893] [10.1021/jm00349a603] |